Index Investing News
Friday, May 30, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

IPO Alert: What to look for when Boundless Bio goes public

by Index Investing News
March 27, 2024
in Markets
Reading Time: 2 mins read
A A
0
Home Markets
Share on FacebookShare on Twitter


Boundless Bio is preparing to debut on the Nasdaq stock market this week, to become the latest addition to the list of biotech firms that have launched IPOs this year. Backed by Bayer, the company develops therapeutics for oncogene-amplified cancers. With a market cap of around $356 million, Boundless Bio is specialized in extrachromosomal DNA which causes oncogene amplification in cancer patients.

The company will issue around 6.3 million shares at an offer price in the range of $15 per share to $17 per share. At the mid-point of the offer price, the company will raise up to $101 million in its initial public offering, if underwriters exercise their option to purchase additional shares in full. The IPO is managed by Goldman Sachs, Leerink Partners, Piper Sandler, and Guggenheim Securities. After listing, the stock will trade on the Nasdaq stock exchange under the symbol BOLD.

Use of Proceeds

The San Diego-based healthcare firm, which was founded in 2018, intends to use proceeds from the offering, together with existing cash and cash equivalents, mainly to fund the research and development of its ecDTx, ecDNA diagnostic tests, and Spyglass platform. The remaining proceeds will be used for working capital and general corporate purposes.

Of late, there has been a steady increase in biotech IPOs — eight biotechnology companies have gone public in the US so far this year. Combined, they raised a total of about $1.2 billion, marking a sharp increase from the total raised in the comparable periods in each of the last two years. The upcoming IPO should elicit significant interest among investors because Boundless Bio is probably the first company to focus on treating oncogene-amplified cancers.

For fiscal 2023, the company reported a net loss of $49.43 million, which is wider than the $45.9 million loss it incurred in the previous year. At $54.8 million, total operating expenses were up 18%. At the end of the year, Boundless Bio had cash, cash equivalents, and short-term investments of around $121 million.

Clinical Trial

Boundless Bio’s lead ecDNA-directed therapy, BBI-355, is currently being studied in a first-in-human Phase 1/2 clinical trial in patients with oncogene-amplified cancers. The study is called Precision Oncology Trial Evaluating Novel Therapeutic Interrupting Amplifications Tied to ecDNA. Besides that, the company has identified a second CHK1 inhibitor candidate with a differentiated profile — BBI-098 is an oral, selective CHK1 inhibitor that demonstrates central nervous system penetrance in preclinical models.



Source link

Tags: alertBioBoundlessIPOPublic
ShareTweetShareShare
Previous Post

5 Crucial Investment Criteria for Out-of-State Turnkey Investors

Next Post

How ​​Can You Invest in Anthropic Stock?

Related Posts

What to search for when Signet Jewelers (SIG) stories Q1 2026 earnings outcomes

What to search for when Signet Jewelers (SIG) stories Q1 2026 earnings outcomes

by Index Investing News
May 30, 2025
0

Shares of Signet Jewelers Restricted (NYSE: SIG) have been down 1% on Friday. The inventory has gained 26% over the...

What a federal commerce courtroom block on Trump tariffs means for shoppers

What a federal commerce courtroom block on Trump tariffs means for shoppers

by Index Investing News
May 30, 2025
0

President Donald Trump holds a chart as he proclaims a plan for tariffs on imported items throughout an occasion April...

U.S.-China talks ‘stalled’ and want Trump and Xi to weigh in, Bessent says

U.S.-China talks ‘stalled’ and want Trump and Xi to weigh in, Bessent says

by Index Investing News
May 30, 2025
0

The U.S. and Chinese language flags are seen on the day of a bilateral assembly between the U.S. and China,...

Costco (COST) Q3 2025 earnings beat estimates; gross sales up 8%

Costco (COST) Q3 2025 earnings beat estimates; gross sales up 8%

by Index Investing News
May 29, 2025
0

Warehouse large Costco Wholesale Company (NASDAQ: COST) reported a rise in revenue for the third quarter of 2025, pushed by...

Kohl’s Company stories narrower web loss for Q1 2025; gross sales down 4%

Kohl’s Company stories narrower web loss for Q1 2025; gross sales down 4%

by Index Investing News
May 30, 2025
0

Kohl’s Company (NYSE: KSS) reported a narrower web loss for the primary quarter of 2025. The division retailer chain’s web...

Next Post
How ​​Can You Invest in Anthropic Stock?

How ​​Can You Invest in Anthropic Stock?

Supercharge Your Portfolio With Top-Performing Tech Stocks!

Supercharge Your Portfolio With Top-Performing Tech Stocks!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Anne Fletcher returning to direct from Jen D’Angelo script

Anne Fletcher returning to direct from Jen D’Angelo script

June 7, 2023
More Black women are becoming homeowners — it doesn’t mean it’s easier

More Black women are becoming homeowners — it doesn’t mean it’s easier

February 20, 2024
How FDIC insurance could bring Bitcoin to the masses

How FDIC insurance could bring Bitcoin to the masses

October 20, 2022
Women need to stop shaming men for being ‘too masculine’

Women need to stop shaming men for being ‘too masculine’

November 12, 2022
Nothing New Thing Under the Sun: Prohibition, Drugs and the Iron Law

Nothing New Thing Under the Sun: Prohibition, Drugs and the Iron Law

April 4, 2024
Digital privateness and advertising – The Hindu BusinessLine

Digital privateness and advertising – The Hindu BusinessLine

January 12, 2025
U.S. stocks mixed after retail earnings, Fed minutes By Investing.com

U.S. stocks mixed after retail earnings, Fed minutes By Investing.com

August 17, 2023
India’s WPI inflation cools to three-month low of 1.89% in November

India’s WPI inflation cools to three-month low of 1.89% in November

December 16, 2024
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In